Status:
RECRUITING
Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF
Lead Sponsor:
Yonsei University
Conditions:
Heart Failure
Cardiomyopathies
Eligibility:
All Genders
20+ years
Brief Summary
"Despite significant advances in pharmacologic and device-based therapies, heart failure (HF) remains a major public health burden, with persistently high rates of hospitalization, impaired quality of...
Detailed Description
"Study Methods 1. Eligible participants will be approached during outpatient visits or hospitalization. The purpose and procedures of the study will be explained in detail, and informed consent will ...
Eligibility Criteria
Inclusion
- Patients aged between 20 and 79 years with a left ventricular ejection fraction of 40% or less (assessed by transthoracic echocardiography), who have provided written consent for participation, have the capability to consent voluntarily
Exclusion
- Inability to obtain high-quality fundus photographs due to severe ophthalmologic conditions
- Presence of extensive retinal diseases that significantly impair visualization of the retinal vasculature
- Decline to provide informed consent for study participation, including:
- Pregnant individuals
- Individuals lacking decision-making capacity
Key Trial Info
Start Date :
December 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06978998
Start Date
December 10 2024
End Date
December 10 2030
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance hospital
Seoul, South Korea